Back to Search Start Over

Acute toxicity related to misuse (nonmedical use) of tramadol: Experience of the European Drug Emergencies Network Plus

Authors :
Layne, Kerry
Dargan, Paul
Dines, Alison
Leaper, Craig
Yates, Christopher
Hovda, Knut Erik
Heyerdahl, Fridtjof
Archer, John R.H.
Giraudon, Isabelle
Wood, David
Anand, Lukasz
Anseeuw, Kurt
Badaras, Robertas
Bonnici, Jeffrey
Brvar, Miran
Burke, Rachel
Caganova, Blazena
Ceschi, Alessandro
Eyer, Florian
Galicia, Miguel
Geith, Stefanie
Gillebeert, Johan
Grenc, Damjan
Gorozia, Ketevan
Jaffal, Karim
Jürgens, Gesche
Konstari, Jutta
Kutubidze, Soso
Laubner, Gabija
Liakoni, Evangelia
Liechti, Matthias
Liguts, Viesturs
Lyphout, Cathelijne
Mégarbane, Bruno
Miró, Òscar
Moughty, Adrian
Noseda, Roberta
O'Connor, Niall
Paasma, Raido
Perez, Juan Ortega
Perminas, Marius
Persett, Per Sverre
Põld, Kristiina
Puiguriguer, Jordi
Radenkova-Saeva, Julia
Rulisek, Jan
Schmid, Yasmin
Scholz, Irene
Sopirala, Radhika
Stašinskis, Roberts
Surkus, Jonas
Toth, Ibolya
Vallersnes, Odd Martin
Vigorita, Federico
Waldman, Wojciech
Waring, W. Stephen
Zacharov, Sergej
Guy's and St Thomas' Hospital [London]
King‘s College London
Hospital Universitari Son Espases
Oslo University Hospital [Oslo]
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Observatoire Européen des Drogues et des Toxicomanies
Service de Réanimation Médicale et Toxicologique [Hôpital Lariboisière]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144))
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
Euro-DEN Plus Research Group
Mégarbane, Bruno
Source :
British Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, 2021, 87 (4), pp.1668-1675. ⟨10.1111/bcp.14408⟩
Publication Year :
2020

Abstract

International audience; Following the development of the tramadol crisis currently affecting countries in the Middle East, and Africa, there has been increasing international interest in the regulation of tramadol. This study investigates the misuse of tramadol in patients presenting to emergency departments across Europe. Data from 32 emergency departments in 21 countries were extracted from the Euro-DEN Plus database for the 4-year period from 1 January 2014 to 31 December 2017. Of the reported 24,957 emergency department presentations, tramadol misuse was reported in 105 (0.4% presentations). Tramadol misuse was most common in Bratislava (Slovakia; n = 11, 7.5% of all presentations to this centre), Riga (Latvia; n = 4, 4.9%) and Munich (Germany; n = 17, 2.9%). On arrival, 14 (13.3%) of presentations were in coma/Glasgow coma score ≤ 8 and 9 of these had a respiratory rate

Details

ISSN :
13652125 and 03065251
Volume :
87
Issue :
4
Database :
OpenAIRE
Journal :
British journal of clinical pharmacologyREFERENCES
Accession number :
edsair.doi.dedup.....bf9697e8e7284a0352de751895d3e90f